Shiao Tong

522 total citations
28 papers, 361 citations indexed

About

Shiao Tong is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Shiao Tong has authored 28 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Shiao Tong's work include Ferroptosis and cancer prognosis (15 papers), Glioma Diagnosis and Treatment (10 papers) and Immune cells in cancer (5 papers). Shiao Tong is often cited by papers focused on Ferroptosis and cancer prognosis (15 papers), Glioma Diagnosis and Treatment (10 papers) and Immune cells in cancer (5 papers). Shiao Tong collaborates with scholars based in China and United States. Shiao Tong's co-authors include Jiayang Cai, Qianxue Chen, Zhang Ye, Daofeng Tian, Lun Gao, Liguo Ye, Yang Xu, Shenqi Zhang, Qian Sun and Qian Sun and has published in prestigious journals such as Frontiers in Immunology, Experimental Cell Research and International Journal of Biological Macromolecules.

In The Last Decade

Shiao Tong

27 papers receiving 359 citations

Peers

Shiao Tong

PRM

IMMUN

ONCOL

Liguo Ye China

Xinke Xu China

Xiaohua Jie China

Teresita Reiner United States

Caihong Sun China

Laurène Froment Switzerland

Seon Yong Lee South Korea

Guilong Tanzhu China

Yongkang Zou China

Liguo Ye China

Shiao Tong

141 ×0.8

124 ×0.9

PRM

114 ×0.9

50 ×0.7

IMMUN

54 ×0.7

ONCOL

Citations per year, relative to Shiao Tong Shiao Tong (= 1×) peers Liguo Ye

Countries citing papers authored by Shiao Tong

Since Specialization

Citations

This map shows the geographic impact of Shiao Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiao Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiao Tong more than expected).

Fields of papers citing papers by Shiao Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiao Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiao Tong. The network helps show where Shiao Tong may publish in the future.

Co-authorship network of co-authors of Shiao Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Shiao Tong. A scholar is included among the top collaborators of Shiao Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiao Tong. Shiao Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tong, Shiao, et al.. (2024). Identification of MDK as a Hypoxia- and Epithelial–Mesenchymal Transition-Related Gene Biomarker of Glioblastoma Based on a Novel Risk Model and In Vitro Experiments. Biomedicines. 12(1). 92–92. 5 indexed citations

Gao, Lun, Shiao Tong, Junhui Liu, et al.. (2023). TMEM2 induces epithelial-mesenchymal transition and promotes resistance to temozolomide in GBM cells. Heliyon. 9(6). e16559–e16559. 5 indexed citations

Tong, Shiao, et al.. (2023). Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas. Journal of Cancer Research and Clinical Oncology. 149(12). 9857–9876. 4 indexed citations

Tong, Shiao, Yang Xu, Qian Sun, et al.. (2023). TFR2 regulates ferroptosis and enhances temozolomide chemo-sensitization in gliomas. Experimental Cell Research. 424(1). 113474–113474. 24 indexed citations

Wang, Jiajing, et al.. (2023). Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification. Frontiers in Immunology. 14. 1128151–1128151. 5 indexed citations

Wang, Yixuan, Yuntao Li, Qian Sun, et al.. (2022). BCAS3 accelerates glioblastoma tumorigenesis by restraining the P53/GADD45α signaling pathway. Experimental Cell Research. 417(2). 113231–113231. 4 indexed citations

Cai, Jiayang, Yuanyuan Hu, Zhang Ye, et al.. (2022). Exploring the inverse association of glioblastoma multiforme and Alzheimer’s disease via bioinformatics analysis. Medical Oncology. 39(12). 182–182. 5 indexed citations

Cai, Jiayang, Zhang Ye, Yuanyuan Hu, et al.. (2022). FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration. Frontiers in Oncology. 12. 998336–998336. 4 indexed citations

Ye, Zhang, Lun Gao, Jiayang Cai, et al.. (2022). Esterase-responsive and size-optimized prodrug nanoparticles for effective intracranial drug delivery and glioblastoma treatment. Nanomedicine Nanotechnology Biology and Medicine. 44. 102581–102581. 9 indexed citations

10.

Zhang, Shenqi, Jiayang Cai, Liguo Ye, et al.. (2022). Development and validation of cuproptosis-associated prognostic signatures in WHO 2/3 glioma. Frontiers in Oncology. 12. 967159–967159. 16 indexed citations

11.

Li, Yong, Yixuan Wang, Lun Gao, et al.. (2022). Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma. Journal of Nanobiotechnology. 20(1). 39–39. 30 indexed citations

12.

Tong, Shiao, Liguo Ye, Yang Xu, et al.. (2022). IRF2-ferroptosis related gene is associated with prognosis and EMT in gliomas. Translational Oncology. 26. 101544–101544. 6 indexed citations

13.

Cai, Jiayang, Lun Gao, Yixuan Wang, et al.. (2022). TMBIM1 promotes proliferation and attenuates apoptosis in glioblastoma cells by targeting the p38 MAPK signalling pathway. Translational Oncology. 19. 101391–101391. 8 indexed citations

14.

Cai, Jiayang, Yuanyuan Hu, Zhang Ye, et al.. (2022). Immunogenic cell death-related risk signature predicts prognosis and characterizes the tumour microenvironment in lower-grade glioma. Frontiers in Immunology. 13. 1011757–1011757. 39 indexed citations

15.

Zhang, Chunyu, Haitao Liu, Yinqiu Tan, et al.. (2022). MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients. Frontiers in Immunology. 13. 865020–865020. 15 indexed citations

16.

Gao, Lun, Zhang Ye, Junhui Liu, et al.. (2022). TMCO1 expression promotes cell proliferation and induces epithelial–mesenchymal transformation in human gliomas. Medical Oncology. 39(7). 90–90. 8 indexed citations

17.

Ye, Liguo, Long Wang, Jian Yang, et al.. (2021). Identification of Tumor Antigens and Immune Landscape in Glioblastoma for mRNA Vaccine Development. Frontiers in Genetics. 12. 701065–701065. 19 indexed citations

18.

Ye, Liguo, Long Wang, Jian Yang, et al.. (2021). Identification of tumor antigens and immune subtypes in lower grade gliomas for mRNA vaccine development. Journal of Translational Medicine. 19(1). 352–352. 18 indexed citations

19.

Xu, Yang, Liguo Ye, Rongxin Geng, et al.. (2021). Development and Verification of the Amino Metabolism-Related and Immune-Associated Prognosis Signature in Gliomas. Frontiers in Oncology. 11. 774332–774332. 4 indexed citations

20.

Zhang, Chunyu, Zhongzhou Su, Na Luo, et al.. (2021). Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature. Frontiers in Cell and Developmental Biology. 9. 717601–717601. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact